Anti-SARS-CoV-2 antibodies elicited by COVID-19 mRNA vaccine exhibit a unique glycosylation pattern
Open Access
- 24 November 2021
- journal article
- research article
- Published by Elsevier in Cell Reports
- Vol. 37 (11) , 110114
Abstract
No abstract availableKeywords
Funding Information
- Melanoma Research Alliance
- Flight Attendant Medical Research Institute
- Harry J. Lloyd Charitable Trust
- Teva Pharmaceutical Industries
- Benoziyo Endowment Fund for the Advancement of Science
- Israel Cancer Research Fund
- Enoch Foundation
- Israel Cancer Association
- Israel Science Foundation
- Icahn School of Medicine at Mount Sinai
- Mizutani Foundation for Glycoscience
This publication has 33 references indexed in Scilit:
- Diversification of IgG effector functionsInternational Immunology, 2017
- Modulating IgG effector function by Fc glycan engineeringProceedings of the National Academy of Sciences, 2017
- Mouse and human FcR effector functionsImmunological Reviews, 2015
- Anti-HA Glycoforms Drive B Cell Affinity Selection and Determine Influenza Vaccine EfficacyCell, 2015
- FcγR dependent mechanisms of cytotoxic, agonistic, and neutralizing antibody activitiesTrends in Immunology, 2015
- IgG Subclasses and Allotypes: From Structure to Effector FunctionsFrontiers in Immunology, 2014
- The Structural Basis of Antibody-Antigen RecognitionFrontiers in Immunology, 2013
- Human IgG Fc-glycosylation profiling reveals associations with age, sex, female sex hormones and thyroid cancerJournal of Proteomics, 2012
- Changes in Antigen-specific IgG1 Fc N-glycosylation Upon Influenza and Tetanus VaccinationMolecular & Cellular Proteomics, 2012
- The role of differential IgG glycosylation in the interaction of antibodies with FcγRs in vivoCurrent Opinion in Organ Transplantation, 2011